Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
Clinical trial NCT04035811 · COMPLETED
Trial details
- NCT number
- NCT04035811
- Sponsor
- QED Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-12
- Primary completion
- 2025-08-27
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.